Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations

Qihua He, Jun Liu, Xiuyu Cai, Miao He, Caichen Li, Hengrui Liang, Bo Cheng, Xiaojun Xia, Minzhang Guo, Peng Liang, Ran Zhong, Feng Li, Ziwen Yu, Yi Zhao, Limin Ou, Shan Xiong, Jianfu Li, Jianrong Zhang, Jianxing He, Wenhua Liang